🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06211218
Recruiting Observational

Artificial Intelligence for Screening of Multiple Corneal Diseases

NCT06211218 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Eye Hospital
Phase
Observational
Started
2020-12-06
Last updated
2024-11-04

Condition(s) studied

Deep LearningCorneal DiseaseScreening

Investigational drug(s) / intervention(s)

Cornea diseases diagnosed by artificial intelligence algorithm

Cornea diseases diagnosed by artificial intelligence algorithm: An artificial intelligence algorithm was applied to diagnose cornea diseases from slit-lamp images.

Study summary

This study developed a deep learning algorithm based on anterior segment images and prospectively validated its ability to identify corneal diseases.The effectiveness and accuracy of this algorithm was evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: 1. The quality of slit-lamp images should clinical acceptable. 2. More than 90% of the slit-lamp image area including three main regions (sclera, pupil, and lens) are easy to read and discriminate. Exclusion Criteria: 1)Insufficient information for diagnosis.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tiajin Eye Hospital Tianjin Tianjin Municipality Recruiting

More Tianjin Eye Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06211218 on ClinicalTrials.gov ↗ ← All trials in China